Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Skin substitutes & wound grafts · California | Skin substitutes & wound grafts · Florida | |
|---|---|---|
| Surgeons, 2024 | 313 | 307 |
| Medicare fee-for-service cases | 86,283 | 65,607 |
| Growth since 2019 (Medicare FFS) | +22%/yr | +28%/yr |
| Forecast cases (Medicare FFS) | 134,700 in 2030 | 135,200 in 2030 |
| Forecast growth | +7.7%/yr to 2030 | +13%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 15.6 | 16.8 |
| Medicare Advantage share | 56% | 60% |
| Out of hospital | 83% (+24 pts since 2019) | 81% (+45 pts since 2019) |
| Cases per surgeon | 276 | 214 |
| Top 10 surgeons' share | 21% | 14% |
| Surgeons growing | 33 | 14 |
| New since the base year | 232 | 237 |
| Likely to stop billing it | 117 by 2026 | 128 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $3,716 | $5,952 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.